Skip to content
Recall Observatory FDA recall evidence

Drug product

Buprenorphine Transdermal System 5 mcg/hour, 4 transdermal systems/4 disposal units per carton, Rx Only, Manufactured by: 3M Drug Delivery Systems, 19901 Nordhoff street, Northridge, CA 91324 USA, Manufactured for: Teva Pharmaceuticals USA Inc., North Wales, PA 19454, carton NDC: 0093-3656-40, patch NDC: 0093-3656-21.

D-0003-2021

September 04, 2020

Class II

Product summary

Firm
Teva Pharmaceuticals USA
Event
Event 86379
Status
Terminated
Classification
Class II
Quantity
32,543 cartons
Official record key
drug-enforcement:D-0003-2021

Official wording

Reason: Failed Stability Specifications: Below specification result for buprenorphine release rate.

Code information: Lot # 190017, exp. 02/2021; 190161, exp. 08/2021

Distribution pattern: Nationwide in the U.S. and PR

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Failed Stability Specifications